Amgen
Jeff Warnick is a seasoned professional in the pharmaceutical industry with significant expertise in hematology and oncology marketing. Currently serving as Head of US Hematology Sales & Marketing at Amgen since May 2022, Jeff leads a talented team in driving sales and marketing initiatives. Prior to this role, Jeff spent over 15 years at Bristol Myers Squibb, where notable positions included Executive Director and Worldwide Lead for the ABECMA Multiple Myeloma Cell Therapy Franchise and Global Commercial Lead for the IMiD Portfolio. Jeff's career also involved progressive roles in immuno-oncology marketing and sales operations, consistently demonstrating a strong track record in sales growth and marketing strategy execution. Jeff holds a Bachelor of Science degree in Business Management with a focus on Marketing from Brigham Young University - Idaho.
Amgen
275 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.